Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium.
about
A Mathematical Model of Neonatal Rat Atrial Monolayers with Constitutively Active Acetylcholine-Mediated K+ CurrentConstitutively Active Acetylcholine-Dependent Potassium Current Increases Atrial Defibrillation Threshold by Favoring Post-Shock Re-Initiation.Mathematical models of canine right and left atria cardiomyocytes.Effects of the novel amiodarone-like compound SAR114646A on cardiac ion channels and ventricular arrhythmias in rats.Attenuation of acetylcholine activated potassium current (I KACh) by simvastatin, not pravastatin in mouse atrial cardiomyocyte: possible atrial fibrillation preventing effects of statin.Recent advances in the molecular pathophysiology of atrial fibrillation.Novel pharmacological targets for the rhythm control management of atrial fibrillation.Hypercholesterolemia induces up-regulation of KACh cardiac currents via a mechanism independent of phosphatidylinositol 4,5-bisphosphate and GβγAblation of sarcolipin results in atrial remodelingEffects of acetylcholine and noradrenalin on action potentials of isolated rabbit sinoatrial and atrial myocytes.Atrial tachycardia induces remodelling of muscarinic receptors and their coupled potassium currents in canine left atrial and pulmonary vein cardiomyocytes.More types than one: multiple muscarinic receptor coupled K+ currents undergo remodelling in an experimental model of atrial fibrillationInnovative approaches to anti-arrhythmic drug therapy.Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.Tissue-specific effects of acetylcholine in the canine heart.Potential Role of Regulator of G-Protein Signaling 5 in the Protection of Vagal-Related Bradycardia and Atrial Tachyarrhythmia.The developmental basis of adult arrhythmia: atrial fibrillation as a paradigm.Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis.The emerging role of antiarrhythmic compounds with atrial selectivity in the management of atrial fibrillation.New pharmacological strategies for the treatment of atrial fibrillationAtrial fibrillation: mechanisms, therapeutics, and future directions.New developments in atrial antiarrhythmic drug therapy.Atrial remodeling in atrial fibrillation and some related microRNAs.Novel molecular targets for atrial fibrillation therapy.miRNA in the regulation of ion channel/transporter expression.Adenosine-guided radiofrequency catheter ablation of atrial fibrillation: A meta-analysis of randomized control trials.Testing Of Box Lesion By Adenosine.How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?Electrophysiological models for the heterogeneous canine atria: computational platform for studying rapid atrial arrhythmias.Effect of input resistance voltage-dependency on DC estimate of membrane capacitance in cardiac myocytes.How Do Atrial-Selective Drugs Differ From Antiarrhythmic Drugs Currently Used in the Treatment of Atrial Fibrillation?Cellular bases for human atrial fibrillation.The effects of tertiapin-Q on responses of the sinoatrial pacemaker of the guinea-pig heart to vagal nerve stimulation and muscarinic agonists.Comparison of the effects of IK,ACh, IKr, and INa block in conscious dogs with atrial fibrillation and on action potentials in remodeled atrial trabeculae.Simulation of Ca2+-activated Cl- current of cardiomyocytes in rabbit pulmonary vein: implications of subsarcolemmal Ca2+ dynamics.Computational Modeling of Electrophysiology and Pharmacotherapy of Atrial Fibrillation: Recent Advances and Future Challenges
P2860
Q28552038-6CF1CD22-0F8A-4EF7-9ADF-EC0976B7CD99Q30669779-D52F1311-28A7-4D66-8CA4-92B6FF222827Q33892635-C8BDEBD9-6C2B-4DF4-9533-ECA16861611DQ33964046-7C366AA7-3B61-4513-9AA0-0CC8639FAC40Q34351005-2B9E79A2-6460-4F10-8017-EA33F96BA5F7Q35142870-1C9CE643-F2D0-4F52-806E-3DFCF909347BQ35489060-D6D5BEF6-3CE0-4524-9EE8-DC0AE6242EBBQ35763074-BDC6BA0F-BA03-48B6-835D-D08D09CBEC39Q36041897-C39C9B8A-8E9E-447D-9A49-499A9D0F8533Q36065088-948EB9D6-C3E5-4829-ADE5-34391EAEF8C9Q36171356-08E4BD28-30C6-4A29-BA51-CD38C2DD52D7Q36171387-C9D3D098-53CA-4C70-830A-691E67EC0106Q36670460-5113640E-BC9C-4B80-8DFE-024F8C8C794FQ36788875-B21EC1C6-84C0-45A4-8C0A-5A4939EF0837Q37054946-617E5757-BF3F-4772-94BA-793E9009ADD0Q37090754-3744DCC4-B378-498B-A178-A5A6929B07C3Q37166226-B4D79A10-A123-4BCA-A9D7-A27B8A2BC9A0Q37282970-868719A3-565B-4916-8D1B-253D91AA4ED4Q37402218-B8AE9172-AF93-496B-B8CD-1B1673CD42EDQ37554693-6C83D056-942D-4F86-AE57-B357EF936CDDQ37590158-CB5FA391-B893-47BD-BD34-3EBF68135AB9Q37697498-8FDECFDC-6F1A-446B-822D-0C0A76339159Q37969565-4D66CA4D-75DF-418A-AC69-558CAB36BB6CQ37998312-8EE90D12-773B-436E-9485-E1A04536F271Q38110520-D9782006-8886-49E7-B5FA-9C443D765EF4Q38647796-55AAE2E4-B88C-41BB-9ED0-5C0974C832CAQ38790270-5E3A0BE8-5745-4165-AE83-4C76FEAA5143Q38790685-AA42CC46-685E-4D5B-BEA0-FEC45A142D79Q42040196-75AB0BA6-7D53-4944-B3F2-DA509D9617ECQ42084818-4E79D1B2-45F9-4219-90A4-7DAD87B23CADQ42385429-F150AC39-3FFE-42EE-979D-2016A1882B06Q43012896-660034A1-B59D-4AF5-8DE8-399E7F3D7A26Q46410232-97E9DA49-7BCE-412A-A62D-F9F4C9CEBAC0Q47254019-6B28AE64-9D15-4FF7-B3CE-91D7CE790DEFQ51943916-195E9A05-9336-4BBA-BFDA-6ACEB4E0006AQ57161239-CA68BF10-4293-4947-908A-25D01DEE3EB7
P2860
Characterization of a hyperpolarization-activated time-dependent potassium current in canine cardiomyocytes from pulmonary vein myocardial sleeves and left atrium.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Characterization of a hyperpol ...... rdial sleeves and left atrium.
@en
Characterization of a hyperpol ...... rdial sleeves and left atrium.
@nl
type
label
Characterization of a hyperpol ...... rdial sleeves and left atrium.
@en
Characterization of a hyperpol ...... rdial sleeves and left atrium.
@nl
prefLabel
Characterization of a hyperpol ...... rdial sleeves and left atrium.
@en
Characterization of a hyperpol ...... rdial sleeves and left atrium.
@nl
P2093
P2860
P1476
Characterization of a hyperpol ...... rdial sleeves and left atrium.
@en
P2093
Denis Chartier
Joachim R Ehrlich
Liming Zhang
Louis Villeneuve
Tae-Joon Cha
Terence E Hébert
P2860
P304
P356
10.1113/JPHYSIOL.2004.061119
P407
P577
2004-03-12T00:00:00Z